Innovating Works
TreatER: Clinical study in Parkinson s disease with two unique goals 1 Proof of concept of CDNF protein for... Renishaw Ireland Ltd participó en un H2020: H2020-SC1-2016-2017 The main focus of TreatER is conducting a randomized, placebo-controlled, first-in-human, proof-of-concept, safety and efficacy study of int...
2016-12-09 - 2020-12-31 | Financiado
ACTIVE: Active Constraints Technologies for Ill defined or Volatile Environments Renishaw Ireland Ltd participó en un FP7: The ACTIVE project exploits ICT and other engineering methods and technologies for the design and development of an integrated redundant rob...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.